IRadimed (Germany) Performance
| 46K Stock | EUR 89.50 3.00 3.47% |
On a scale of 0 to 100, IRadimed holds a performance score of 27. The company retains a Market Volatility (i.e., Beta) of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IRadimed's returns are expected to increase less than the market. However, during the bear market, the loss of holding IRadimed is expected to be smaller as well. Please check IRadimed's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether IRadimed's current trending patterns will revert.
Risk-Adjusted Performance
Strong
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in IRadimed are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, IRadimed reported solid returns over the last few months and may actually be approaching a breakup point. ...more
IRadimed |
IRadimed Relative Risk vs. Return Landscape
If you would invest 6,156 in IRadimed on October 20, 2025 and sell it today you would earn a total of 2,794 from holding IRadimed or generate 45.39% return on investment over 90 days. IRadimed is currently producing 0.6319% returns and takes up 1.8371% volatility of returns over 90 trading days. Put another way, 16% of traded stocks are less volatile than IRadimed, and 88% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
IRadimed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRadimed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IRadimed, and traders can use it to determine the average amount a IRadimed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.3439
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 46K | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.84 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.63 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.34 actual daily | 27 73% of assets perform better |
Based on monthly moving average IRadimed is performing at about 27% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IRadimed by adding it to a well-diversified portfolio.
IRadimed Fundamentals Growth
IRadimed Stock prices reflect investors' perceptions of the future prospects and financial health of IRadimed, and IRadimed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IRadimed Stock performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 288.03 M | |||
| Shares Outstanding | 12.57 M | |||
| Price To Earning | 452.94 X | |||
| Price To Book | 5.06 X | |||
| Price To Sales | 6.78 X | |||
| Revenue | 53.3 M | |||
| EBITDA | 15.63 M | |||
| Cash And Equivalents | 56.11 M | |||
| Cash Per Share | 4.55 X | |||
| Total Debt | 2.61 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 5.86 X | |||
| Cash Flow From Operations | 11.26 M | |||
| Earnings Per Share | 0.99 X | |||
| Total Asset | 85.51 M | |||
About IRadimed Performance
By analyzing IRadimed's fundamental ratios, stakeholders can gain valuable insights into IRadimed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IRadimed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IRadimed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devices, and related accessories and services in the United States and internationally. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. IRADIMED CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people.Things to note about IRadimed performance evaluation
Checking the ongoing alerts about IRadimed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IRadimed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 44.0% of the company shares are owned by insiders or employees |
- Analyzing IRadimed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IRadimed's stock is overvalued or undervalued compared to its peers.
- Examining IRadimed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IRadimed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IRadimed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IRadimed's stock. These opinions can provide insight into IRadimed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for IRadimed Stock analysis
When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |